Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “sequence”

165 pharma patents match "sequence" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 165
Index total 30,257
Page 2 / 7

Quick answer

This filtered view shows 165 pharmaceutical patents matching "sequence" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

165 results for “sequence” · 30,257 patents in full index Clear search

  1. US 11246930

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  2. US 11213593

    Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates

    Northwestern University · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted
  3. US 11192923

    Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

    Theradaptive, Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  4. US 11162945

    Methods and compositions for detecting single T cell receptor affinity and sequence

    The Board of Regents of the University of Texas System · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted
  5. US 11155803

    Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence

    Beam Therapeutics Inc. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  6. US 11142750

    Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome

    Precision BioSciences, Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  7. US 11124545

    Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

    Inovio Pharmaceuticals, Inc. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted
  8. US 10982212

    Conserved HBV and HCV sequences useful for gene silencing

    Alnylam Pharmaceuticals, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  9. US 10851358

    Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome

    Precision BioSciences, Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  10. US 10799535

    Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene

    Precision BioSciences, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  11. US 10759833

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  12. US 10662416

    Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome

    Precision BioSciences, Inc. · Granted May 26, 2020 · Expires May 21, 2040

    granted
  13. US 10596260

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted
  14. US 10435695

    Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interferon amino acid sequences

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  15. US 10323070

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  16. US 10118961

    Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV

    CytomX Therapeutics, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  17. US 10041053

    Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

    Precision BioSciences, Inc. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  18. US 10039827

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  19. US 9993545

    Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

    Inovio Pharmaceuticals, Inc. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  20. US 9982263

    Conserved HBV and HCV sequences useful for gene silencing

    Alnylam Pharmaceuticals, Inc. · Granted May 29, 2018 · Expires May 24, 2038

    granted
  21. US 9937196

    Genomic sequence of avian paramyxovirus type 2 and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted
  22. US 9670254

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  23. US 9605255

    Oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell

    ProQR Therapeutics II B.V. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  24. US 9518096

    Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

    Takeda Vaccines, Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted